• 1
    Anderson J.P., Sambamurti K., Esch F.S., Keim P.S., Lieberburg I., Robakis N.K. (1991) Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci. Lett. 128 126129.
  • 2
    Anderson J.P., Chen Y., Kim K.S., Robakis N.K. (1992) An alternative secretase cleavage produces soluble Alzheimer amyloid precursor protein containing a potentially amyloidogenic sequence. J. Neurochem. 59 23282331.
  • 3
    Barrett A.J., Kembhavi A.A., Brown M.A., Kirschke H., Knight C.C., Tamai M., Hanada K. (1982) L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J. 201 189198.
  • 4
    Cai X.D., Golde T.E., Younkin S.G. (1993) Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259 514516.
  • 5
    Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D.J. (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature 360 672674.
  • 6
    Citron M., Diehl T.S., Gordon G., Biere A.L., Seubert P., Selkoe D.J. (1996) Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA 93 1317013175.
  • 7
    Efthimiopoulos S., Felsenstein K.M., Sambamurti K., Robakis N.K., Refolo L.M. (1994) Study of the phorbol ester effect on Alzheimer amyloid precursor processing: sequence requirements and involvement of a cholera toxin sensitive protein. J. Neurosci. Res. 38 8190.
  • 8
    Efthimiopoulos S., Vassilacopoulou D., Ripellino J.A., Tezapsidis N., Robakis N.K. (1996) Cholinergic agonists stimulate secretion of soluble full length APP in neuroendocrine cells. Proc. Natl. Acad. Sci. USA 93 80468050.
  • 9
    Ghiso J., Matsubara E., Koudinov A., Choi-Miura N.H., Tomita M., Wisniewski T., Frangione B. (1993) The cerebrospinal-fluid soluble form of Alzheimer’s amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293 2730.
  • 10
    Higaki J., Quon D., Zhong Z., Cordell B. (1995) Inhibition of beta-amyloid formation identifies proteolytic precursors and subcellular site of catabolism. Neuron 14 651659.
  • 11
    Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. (1987) The preA4(695) precursor protein of Alzheimer’s disease A4 amyloid is encoded by 16 exons. Nature 325 733736.
  • 12
    Klafki H., Paganetti P.A., Sommer B., Staufenbiel M. (1995) Calpain inhibitor I decreases beta A4 secretion from human embryonal kidney cells expressing beta-amyloid precursor protein carrying the APP670/671 double mutation. Neurosci. Lett. 201 2932.
  • 13
    Klafki H., Abramowski D., Swoboda R., Paganetti P.A., Staufenbiel M. (1996) The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities. Neurosci. Lett. 201 2932.
  • 14
    Knops J., Suomensaari S., Lee M., McConologue L., Seubert P., Sinha S. (1995) Cell-type and amyloid precursor protein-type specific inhibition of A beta release by bafilomycin A1, an elective inhibitor of vacuolar ATPases. J. Biol. Chem. 270 24192422.
  • 15
    Levy O.E., Semple J.E., Lim M.L., Reiner J., Rote W.E., Dempsey E., Richard B.M., Zhang E., Tulinsky A., Ripka W.C., Nutt R.F. (1996) Potent and selective thrombin inhibitors incorporating the constrained arginine mimic 1-3-piperidyl(N-guanidino)alanine at P1. J. Med. Chem. 39 45274530.DOI: 10.1021/jm960607j
  • 16
    McGowan E.B., Becker E., Detwiler T.C. (1989) Inhibition of calpain in intact platelets by the thiol protease inhibitor E64d. Biochem. Biophys. Res. Commun. 158 432435.
  • 17
    Mehta P.D., Dalton A.J., Mehta S.P., Kim K.S., Sersen E.A., Wisniewski H.M. (1998) Increased plasma amyloid beta protein 1-42 levels in Down syndrome. Neurosci. Lett. 241 1316.
  • 18
    Miller D.L., Papayannopoulos I.A., Styles J., Bobin S.A., Lin Y.Y., Biemann K., Iqbal K. (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer’s disease. Arch. Biochem. Biophys. 301 4152.
  • 19
    Pereira M.E., Yu B., Wilk S. (1992) Enzymatic changes of the bovine pituitary multicatalytic proteinase complex, induced by magnesium ions. Arch. Biochem. Biophys. 294 18.
  • 20
    Robakis N.K. (1994) β-Amyloid and amyloid precursor protein: chemistry, molecular biology, and neuropathology, in Alzheimer’s Disease (Terry R., Kattman R., and Bicke E., eds), pp. 317326. Raven Press, New York.
  • 21
    Roher A.E., Lowenson J.D., Clarke S., Woods A.S., Cotter R.J., Gowing E., Ball M.J. (1993) β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. USA 90 1083610840.
  • 22
    Salvesen G. & Nagase H. (1989) Inhibition of proteolytic enzymes, in Proteolytic Enzymes, A Practical Approach (Beynon R. J. and Bond J. S., eds), pp. 83104. Oxford University Press, Oxford.
  • 23
    Seubert P., Oltersdorf T., Lee M.G., Barbour R., Blomqist C., Davis D.L., Bryant K., Fritz L.C., Galasko D., Thai L.J., Lieberburg I., Schenk D.B. (1993) Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 361 260263.
  • 24
    Tezapsidis N., Noctor S., Kannan R., Krieger T.J., Mende-Mueller L., Hook V.Y. (1995) Stimulation of “prohormone thiol protease” (PTP) and [Met]enkephalin by forskolin. Blockade of elevated [Met]enkephalin by a cysteine protease inhibitor of PTP. J. Biol. Chem. 270 1328513290.
  • 25
    Thompson R.C. (1973) Use of peptide aldehydes to generate transition state analogs of elastate. Biochemistry 12 4751.
  • 26
    Tischer E. & Cordell B. (1996) Beta-amyloid precursor protein. Location of transmembrane domain and specificity of gamma-secretase cleavage. J. Biol. Chem. 271 2191421919.
  • 27
    Wang K.K.W. (1990) Developing selective inhibitors of calpain. Trends Pharmacol. Sci. 11 139142.
  • 28
    Wolfe M.S., Citron M., Diehl T.S., Xia W., Donkor I.O., Selkoe D.J. (1998) A substrate-based difluoro ketone selectively inhibits Alzheimer’s gamma-secretase activity. J. Med. Chem. 41 69.
  • 29
    Yamazaki T., Haass C., Saido T.C., Omura S., Ihara Y. (1997) Specific increase in amyloid beta-protein 42 secretion ratio by calpain inhibition. Biochemistry 36 83778383.